Gary Emmanuel
McDermott Will & Emery
Articles
SEC Amends Exempt Offering Framework
USA - November 20 2020 On November 2, 2020, the Securities and Exchange Commission (SEC) voted to amend the framework for exempt offerings under the Securities Act of 1933…
Robert H. Cohen, Thomas P. Conaghan, Ze’-ev D. Eiger, Mark J. Mihanovic
SEC Modernizes “Accredited Investor” Definition
USA - August 27 2020 On August 26, 2020, the US Securities and Exchange Commission (the SEC or “Commission”) adopted amendments to the definition of “accredited investor”…
Robert H. Cohen, Thomas P. Conaghan, Diana Douglas, Ze’-ev D. Eiger, Mark J. Mihanovic, Eric Orsic, Mark S. Selinger, Heidi Steele
SEC Provides Further Guidance on COVID-19 Disclosure
USA - July 1 2020 On June 23, 2020, the Division of Corporation Finance (CF) and the Office of the Chief Accountant of the US Securities and Exchange Commission (SEC)…
Richard Bass, Robert H. Cohen, Thomas P. Conaghan, Ze’-ev D. Eiger, Patrick F. Healy, Mark J. Mihanovic, Eric Orsic, Heidi Steele
Capital Markets & Public Companies Quarterly
USA - October 17 2019 On September 6, 2019, the Staff of the Division of Corporation Finance of the US Securities and Exchange Commission (SEC) announced two major changes…
Robert H. Cohen, Thomas P. Conaghan, William Hadler, Mark J. Mihanovic, Thomas J. Murphy, Eric Orsic, Heidi Steele, Daniel L. Woodard
Life Sciences Company Settles Regulation FD Charges with SEC
USA - September 4 2019 On August 20, 2019, the US Securities and Exchange Commission (SEC) charged TherapeuticsMD Inc., a Boca Raton, Florida, headquartered life sciences…
